Hep C was on the decline in the U.S. But between 2006 and 2012, rates more than tripled across Kentucky, Tennessee, West Virginia and Virginia. Rod McCullom reports on the challenges of an increasingly rural epidemic.
According to researchers, most states are violating federal laws by denying coverage for Sovaldi, as well as ignoring scientific evidence, treatment guidelines and clinical data.
Treatment for hepatitis C may be better than ever, but that's not true for access to these drugs. Here's what gets in the way.
The high cost of hepatitis C treatment has inspired lawsuits and protests. Now, activist have targeted the hedge fund investors who they say are reaping profits from the pricey pills. Rod McCullom reports.
As small town and rural opiate use continues to rise, Daniel Raymond of the Harm Reduction Coalition says communities should provide safe disposal rather than lay blame.
African Americans are disproportionately affected by hepatitis C in the US. Thankfully, significant advances in HCV treatment in the past four years may help reverse this trend.
After PrEP for HIV, might there be a pill to protect against other STIs, as well?
With treatment for hepatitis C more effective than ever, can we wipe this infectious disease off the map?
Even after two men in San Francisco who were on PrEP were diagnosed with hepatitis C, advocates hold that PrEP is a valuable tool that should not be dismissed.
STIs can cause health issues from unpleasant to life-threatening, and most of them also increase the likelihood of transmission of HIV. Though consistent condom use is the gold standard of STI prevention, there are other things that MSM can do to pro...